Presentation of Capabilities Reverse Logistics

Similar documents
v Woodfield Distribution, LLC Presentation of Capabilities

Woodfield Distribution, LLC Presentation of Capabilities

Pharmacy Technician H A N D B O O K

In-State Licensee Newsletter January 2007

Prescription Product Supplier Requirements

PHARMACY, MEDICINES & POISONS BOARD

*NOTIFY THE DEPARTMENT IN WRITING OF ANY UPDATES

QUALITY AGREEMENT. The following Agreement has been concluded between

I. Purpose. II. Definitions. Last Approval Date

S P O N S O R E D B Y

INVESTIGATIONAL DRUG MANAGEMENT OVERVIEW

Rev A. Vendor Compliance Manual

GUIDANCE FOR INDUSTRY. Questions and Answers

BSWH Technician Continuing Education 2016 Part 2: Pharmacy Law - Controlled Substance Security & Drug Supply Chain Security Act (DSCSA) Contact

Improving Patient Safety and Supply Chain Efficiency with GS1 Standards in HEALTHCARE

Guidance on Requirements of the Sponsor and the Investigator as a Sponsor

USP800: A quick summary and disposal. Brenda Denson, Pharm.D.

Timeline for the Drug Supply Chain and Security Act

PRODUCT RECALL PROGRAM

ROLE OF THE RESEARCH COORDINATOR Investigational New Drug Application-Sponsor Responsibilities 21CFR Part , subpart D

In-State Licensee Newsletter MAY 2015

10/17/2016. Learning Objectives. What is Drug Accountability. Patricia Novo, MPA, MPH Beth Jeffries, BS, CCRP

Patricia Novo, MPA, MPH Beth Jeffries, BS, CCRP

Procedures for the Use of Controlled Substances in Laboratory and Animal Research

DSCSA: DRUG SUPPLY CHAIN SECURITY ACT AND IMPLEMENTATION. Chris Smith, R.Ph. Director, Pharmacy Business Intelligence Inmar

The Right Prescription for Working with Investigational Drug Service at BMC

June 1, Dear Valued Supplier:

Drug Supply Chain Security Act Implementation Track and Trace Issues in 2017

MAIMONIDES MEDICAL CENTER

WHITE PAPER. Everything You Need To Know About the FDA UDI Rule

POST-IRB APPROVAL FDA DRUG (IND) SPONSOR AND INVESTIGATOR RESPONSIBILITY (21 CFR312)

This guidance is for immediate implementation.

Distribution Capabilities

FOR IMMEDIATE RELEASE

Sarpy County Purchasing Department

SUPPLIER POLICIES AND PROCEDURES

Supply of aseptically - prepared doses of IMPs across legal boundaries. Edition 1. December 2017

Management of Unused Patient Dispensed Medications

Course 80024A Trade and Logistics I in Microsoft Dynamics AX 2009 Course Duration: 3 days Course Type: Instructor-Led/Classroom

RJ International Limited

U.S. Vision Care 2014 Sales Policy & Procedures. January 1, Alcon Laboratories, Inc South Freeway, Fort Worth, Texas

The purpose of these guidelines is to describe a standardized approach for the management of

Human Tissue Intended for Transplantation Skin, corneas, sclera, bone, heart valves, blood vessels, pericardium, tendons, cartilage, fascia

Code of Practice for Holder of Certificate of Registration as an Importer and Exporter of Pharmaceutical Products

REGULATORY LANDSCAPE: UPDATE

STANDARD OPERATING PROCEDURES DIVISION OF COMPARATIVE MEDICINE UNIVERSITY OF SOUTH FLORIDA

Overview of the Drug Supply Chain Security Act. GPhA Fall Technical Conference Bethesda, MD October 28, 2014

Where Quality Meets Flexibility

URGENT: VOLUNTARY PRODUCT RECALL / MARKET WITHDRAWAL ***LIMITED ONLY TO SPECIFIC LOTS OF DAYTRANA***

Product serialization and traceability mandates. kpmg.com

Regulatory Binder: Set-up and Maintenance

Preparing for Close-Out of Studies and Sites

11.0 FDA-Regulated Research

2016 WHITE PAPER. Healthcare Supply Chain Imperatives

Distribution and Trade in Microsoft Dynamics AX 2012

Subj: IMPLEMENTATION AND MANAGEMENT OF PRESCRIPTION DRUG TAKE BACK PROGRAM

What To Do or Not To Do? Utility of Medication Traceability to the Patient

WHITE PAPER. Solutions to Global Pharmaceutical Supply Chain Challenges

INVESTIGATIONAL DRUG SERVICE (IDS) Standard Operating Procedures

MANUFACTURE OF INVESTIGATIONAL MEDICINAL PRODUCTS

U.S. Traceability: the Drug Supply Chain Security Act

EPA Overhauls Rules for Pharmaceutical Wastes That Qualify as RCRA Hazardous Wastes

Drug Supply Chain Security Act Implementation

How Do Holds and Recalls Work with USDA Commodities?

Compliance, Consistency and Flexibility: Three Reasons to Consider an ERP Solution Built for Cosmetics Manufacturing

NCS Global Corporate Presentation

Procedure for Procurement and Receipt

Title: Department: Approved by: Director, Human Research Review and Compliance

Internal Auditor s Report. The County Council and County Executive of Wicomico County, Maryland:

Topics. Safety First Initiative. Drug Safety Communications DRUG SAFETY INITIATIVES AT THE FOOD AND DRUG ADMINISTRATION

Standard Pharmaceutical Product Information (Rx Product Only)

Standard Pharmaceutical Product Information (Rx Product Only)

Standard Pharmaceutical Product Information (Rx Product Only)

ACHIEVING SUPPLY CHAIN EFFICIENCIES THROUGH USE OF AN ELECTRONIC TRADING EXCHANGE FOR HEALTHCARE

Standard Pharmaceutical Product Information (Rx Product Only)

September 9, Mr. Mark A. Thierer Chief Executive Officer OptumRx 1600 McConnor Parkway Schaumburg, IL

Title: Review of Medical Devices Page: 1 of 5 Written by:

Besse Medical Customer CARE Getting Started Guide 1

Standard Pharmaceutical Product Information (Rx Product Only)

POLICY Investigational Drug Service Transport

Contents 1. OVERVIEW APPLICABILITY TRIAL INFORMATION PHARMACY REGISTRATION & SET-UP PHARMACY ACTIVATION PATI

By the end of this exercise the participant/candidate will be able to:

Regulatory Update: The US Drug Supply Chain Security Act (DSCSA) December 2017

Standard Pharmaceutical Product Information (Rx Product Only)

Burlington Stores, Inc. Direct to Consumer Program Manual

GxP Auditing, Remediation, and Staff Augmentation

Verification Systems Under the Drug Supply Chain Security Act for Certain Prescription Drugs Guidance for Industry

HDA Qs and As on the Drug Supply Chain Security Act (DSCSA) VERSION 4.0 June 2016

Pharmaceutical and Biotechnology Services

Push Partner Job Assignment Form

DRUG ORDERING AND MAINTENANCE

Standard Pharmaceutical Product Information (Rx Product Only)

Standard Pharmaceutical Product Information (Rx Product Only)

Standard Pharmaceutical Product Information (Rx Product Only)

Central Fabrication Accreditation PRE-APPLICATION. checklist. American Board for Certification in Orthotics, Prosthetics and Pedorthics, Inc.

PURITAN PRODUCTS QUALITY OVERVIEW. Quality Management System Self-Audit. September 15, 2015

Standard Pharmaceutical Product Information (Rx Product Only)

Standard Pharmaceutical Product Information (Rx Product Only)

Standard Pharmaceutical Product Information (Rx Product Only)

Transcription:

Presentation of Capabilities Reverse Logistics Woodfield Distribution, LLC v081617

Reverse Logistics About Us Description of Services Reverse Distribution Channels DSCSA/Sustainability

About Us WDSrx Woodfield Distribution, LLC Is A Pharmaceutical Logistics Services Provider Offering A Range Of Diversified Solutions To Reduce Costs And Increase Productivity Supply Chain Operations: Order Receipt, Storage, Handling And Fulfillment, Transportation Management, Temperature Regulated Environments, Regulatory Compliant Product Disposition On-site Related Services: Packaging And Labeling, Clinical Trial Support, Kitting, Inbound/Outbound Call Center For Customer Service, Patient Assistance Programs And Physician Outreach, E-Commerce Solutions, Financial Services Including Chargeback Processing Over-The-Counter And Prescription Products Including Controlled Substances (Schedules CII-CV) State Licensed Nationally; Licensed By DEA, FDA, EPA, DOT, VAWD

Description of Services The Process Of Removing Pharmaceutical Drug Products From The Supply Chain Is Known As Reverse Logistics Affects Products That Are Removed From Commercial Sale Or Prevented From Entering The Commercial Market Reverse Logistics Procedures Comply With Strict Regulatory Guidelines Set By Government And Other Regulatory Authorities

Benefits Cost Control Assuring Manufacturer Returns Policies And Guidelines Are Respected Reduce Diversion Assure Medications Are Properly Monitored Once Removed From Commercial Channels Capture Value Potential To Recover Cost Of Returned Products Maintain Compliance Conform To Regulatory Protocols Increase Patient Safety Remove Potentially Harmful Products From Distribution Environmental Protection Utilize Sustainable Destruction Methods With Minimal Environmental Impact Legal Requirement Follow Current Federal, State And Local Statutes

Purpose Expired Product Products That Are Past Their Effective Date R&D Product Failed Batches Unsaleable Products That Fail Stability Testing Are Marked For Destruction Recalls The FDA May Order The Removal Of Products From Distribution Caused By Failed Specifications, Mislabeling Or Other Issues Withdrawals Adverse Patient Reactions Precede Products Being Removed From Sale By The FDA Damages Products With Visible Damage To Outer Or Inner Packaging May Affect Patient Safety Short-Dated Products Medications That Cannot Be Effectively Sold Due To An Approaching Expiration Date

Reverse Distribution Channels Dispensers 1. Log In To Secure Site 2. Upload Inventory 3. Print Label And Ship Commercial Returns 1. Client Accounts Log In To WDSrx 2. Returns Are Processed 3. Accounts Are Administered According To Client Policies Manufacturer Bulk Returns 1. Upload Photo Of Bulk Items 2. Respond To Emailed Form 3. Confirm Fee And Arrange Pick-up Complete Reverse Logistics Orders Online: www.returns.wdsrx.com Nationwide Three Steps To Order Completion

Reverse Distribution Channels Dispensers Products Are Sent To WDSrx Technicians Confirm Contents Match Received Inventory Items Are Sorted And Product Details Entered Into System Controlled Substances (Schedule CII) Require DEA Form 222 Quality Assurance Reviews Are Conducted To Determine Disposition Status Manufacturers Are Notified Of Product Return And Refund Status Upon Approval, Trade Account Is Credited Products To Be Destroyed Are Marked For Regulatory Compliant Disposition Certificate Of Destruction Is Issued After Products Are Converted Hazardous Or Non-Hazardous Destruction Log And Manifest Are Issued Controlled Substances (Schedule CII) Requires DEA Form 41 To Be Issued After Destruction Including Witness Statement

Reverse Distribution Channels Commercial Returns WDSrx Partners With Manufacturers For Complete Returns Administration Service Scope Communication: Client, Accounts, Third-Party Contractors Shipping, Documentation, Verification, Compliance Real-Time Online Information Access And Custom Reporting Reimbursement According To Client Approved Policies Disposition Including Interaction With Government And Regulatory Authorities Recalls And Withdrawal Management Specialized Solutions According To Manufacturer Return Policies Product Range OTC Controlled And Non-Controlled Rx Hazardous And Non-Hazardous Program Benefits Enables Client To Concentrate On Core Competencies Reduces Cost Of In-House Administration Full Track & Trace Serialization Throughout Reverse Distribution Process

Reverse Distribution Channels Manufacturer Bulk Returns Manufacturers Notify WDSrx About A Bulk Waste Order WDSrx Arranges Transport If Required Upon Arrival At WDSrx, Technicians Inventory Each Item Client Is Notified Of Any Discrepancies With Client Approval, Products Enter The Destruction Process Certificate Of Destruction Is Issued After Products Are Converted Hazardous Or Non-Hazardous Destruction Log And Manifest Are Issued Controlled Substances (Schedule CII) Requires DEA Form 41 To Be Issued After Destruction Including Witness Statement

Environmental Protection The WDSrx Headquarters Facility Located In Boca Raton, FL Processed 378,380 Pounds Of Pharmaceutical Drug Products With Covanta Environmental Solutions In 2016 Creating 368 Megawatt Hours Of Electricity Able To Power 33 Homes For An Entire Year. Covanta Environmental Solutions WDSrx Partners With Covanta Environmental Solutions For Destruction Of Pharmaceutical Drug Products Including Controlled Substances (Schedules CII-CV) Covanta Facilities Convert Waste Received For Destruction Into Clean Electric Power Compared With Conventional Incineration Methods The Partnership Between WDSrx And Covanta Environmental Solutions Preserves The Environment, Generates Clean Energy And Prevents Diversion Of Pharmaceutical Drug Products Corporate Responsibility WDSrx Minimizes The Environmental Impact From Destruction Of Pharmaceutical Drug Products Sustainable Business Practices Are A Priority For WDSrx And For Partner Vendors

Serialization/DSCSA Products Must Be Tracked Throughout The Reverse Logistics Process WDSrx Reverse Logistics Operations Are DSCSA-Compliant Ability To Document Product Recall Data To Item-level Detail Ahead Of 2023 Deadline DSCSA Compliance For Reverse Logistics Creates Savings In Time, Labor And Cost Recalls Currently Managed By Lot Level Will Be Targeted To Involve The Precise Individual Units Affected Track And Trace Capability To Access Records From Date And Location Of Original Sale

Contact 951 Clint Moore Road, Suite A Boca Raton, FL 33487 561.998.3885 phone 561.998.3886 fax www.wdsrx.com @WDSrx